Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.
暂无分享,去创建一个
[1] J. Wetterslev,et al. Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome and Acute Lung Injury in Adults and Children: A Systematic Review with Meta-Analysis and Trial Sequential Analysis , 2011, Anesthesia and analgesia.
[2] M. Buckley,et al. Inhaled Epoprostenol for the Treatment of Pulmonary Arterial Hypertension in Critically Ill Adults , 2010, Pharmacotherapy.
[3] R. Shemin,et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. , 2009, The Journal of thoracic and cardiovascular surgery.
[4] T. Evans,et al. Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.
[5] B. Erstad,et al. Retrospective Evaluation of Inhaled Prostaglandins in Patients with Acute Respiratory Distress Syndrome , 2005, Pharmacotherapy.
[6] G. Angelini,et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. , 2004, The Journal of thoracic and cardiovascular surgery.
[7] Brian K Walsh,et al. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery , 2002, Critical care medicine.
[8] J. T. Cope,et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.
[9] T. de Giacomo,et al. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin. , 2001, Journal of cardiothoracic and vascular anesthesia.
[10] S. Ricksten,et al. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. , 1998, Chest.
[11] M. Booke,et al. Inhaled Prostaglandin E1 for Treatment of Acute Lung Injury in Severe Multiple Organ Failure , 1998, Anesthesia and analgesia.
[12] M. Haller,et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[13] P. V. van Heerden,et al. Inhaled Aerosolized Prostacyclin and Nitric Oxide as Selective Pulmonary Vasodilators in ARDS—A Pilot Study , 1996, Anaesthesia and intensive care.
[14] W. Seeger,et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[15] S. Turner,et al. Cost Implications of Using Inhaled Nitric Oxide Compared with Epoprostenol for Pulmonary Hypertension , 1995, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.
[16] R. Rossaint,et al. Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.